Research on a New Intelligent Mobile Screening and Diagnosis Pattern for Ocular Diseases
NCT07003165
Age Related Macular Degeneration (ARMD), Cardiovascular Diseases
View Trial DetailsNCT Number: NCT06966882
There is an imbalance between the supply and demand of eye care services, especially in local communities and remote areas. To address this, it's important to use new intelligent technologies to expand the reach of eye disease screening and treatment. Large language models (LLMs) are a type of deep learning technology that can learn from large amounts of text and generate human-like language to help with medical tasks such as diagnosing diseases and answering health-related questions. The investigator's team has previously developed a localized LLM capable of answering ophthalmology-related medical questions. Building on this, this study plans to use a screening-based trial design to explore how accurately the LLM can make referral decisions for eye diseases, diagnose conditions, recommend appropriate tests, and receive user feedback in real-world community settings. The goal is to improve the ability to screen for eye diseases in grassroots and regional areas.
Trial opening soon.
Get NotifiedAll sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: through study completion, up to 1 year.
Contact information is provided by the study sponsor or research team.
Haotian Lin
CONTACT
Mingjie Luo
CONTACT
Zhongshan Ophthalmic Center, Sun Yat-sen University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07003165
Age Related Macular Degeneration (ARMD), Cardiovascular Diseases
View Trial Details